Alaunos Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Adcock Ingram Holdings ZAR 89.42M 17.72M 2024-06
Alaunos Therapeutics USD 1.68M 780K 2024-09
Amgen USD 11.97B 2.96B 2024-12
AstraZeneca USD 5.49B 691M 2024-12
Baxter International USD 1.76B 344M 2024-12
Biogen USD 2.38B 675.8M 2024-12
Bioline Rx USD 8.84M 787K 2024-09
Bristol-Myers Squibb USD 10.35B 2.46B 2024-12
Celltrion KRW 972.66B 68.24B 2024-09
Corcept Therapeutics USD 127.66M 9.62M 2024-12
Cspc Pharmaceutical 8.37B 3.64B 2024-06
Dianthus Therapeutics USD 33.67M 280.5M 2024-09
Ecofibre AUD 6.74M 4.89M 2024-06
Gilead Sciences USD 9.99B 4.95B 2024-12
GlaxoSmithKline GBP 3.87B 678M 2024-12
Incyte USD 1.69B 383.72M 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
J&J USD 6.12B 1.28B 2024-12
Kangmei Pharma CNY 773.51M 28.83M 2024-09
Knight Therapeutics CAD 5.81M 3.59M 2024-09
Laboratorios Farma EUR 44.58M 31.49M 2024-06
Malin Corporation EUR 35.7M 6.4M 2024-06
Medical Developments International AUD 9.74M 5.96M 2024-06
Merck USD 13.24B 1.35B 2024-12
Neuren Pharmaceuticals AUD 3.15M 582K 2024-12
Novartis USD 8.87B 4.74B 2024-12
Organigram Holdings 79.26M 7.45M 2024-06
Pfizer USD 1.04B 49M 2024-12
Pharma Mar EUR 63.24M 28.44M 2024-12
PTC Therapeutics USD 779.71M 253.71M 2024-12
Qiagen NV USD 663.56M 309.42M 2024-12
Regeneron Pharmaceuticals USD 17.91B 15.9B 2024-12
Roche Holding CHF 6.98B 2.15B 2024-12
Sartorius EUR 579.2M 12M 2024-09
Sino Biopharmaceutical CNY 8.55B 902.41M 2024-06
TG Therapeutics USD 179.89M 15.93M 2024-12
Tilray USD 189.7M 15.49M 2024-11
Zz Pientze Pharmaceu 3.27B 895.19M 2024-09



Alaunos Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.